The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
about
Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysisOvarian serous carcinoma: recent concepts on its origin and carcinogenesisOrigin and molecular pathogenesis of ovarian high-grade serous carcinomaRecent concepts of ovarian carcinogenesis: type I and type IIMolecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theoryNuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer.KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinomaDriver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistryAdenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosisOvarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problemsMolecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Overexpression of the β subunit of human chorionic gonadotropin promotes the transformation of human ovarian epithelial cells and ovarian tumorigenesis.Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series.A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models.Low-grade serous carcinomas of the ovary contain very few point mutationsMolecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.Successful pregnancy following myomectomy for uterine smooth muscle tumor of uncertain malignant potential: A case report and review of the literature.P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer.Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases.Ovarian cancer stroma: pathophysiology and the roles in cancer development.Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity.Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report.Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary.Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.High-grade serous carcinoma of tubo-ovarian origin: recent developments.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Epigenetic biomarkers in the diagnosis of ovarian cancer.Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs.Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
P2860
Q26776018-5BE03926-7979-42C6-9B0F-ACACF29B73BFQ26822545-3338DD1D-C58E-4E7C-AFAB-0F727CC7C016Q26852698-81C5BFBB-7780-4E23-9675-588E1F45D63BQ27009487-F1A348C4-6634-49DE-93E0-80939C952567Q33580777-F281FC0D-2D68-455B-B98F-6E73E1A9E2A2Q33739695-DDBB1617-E17C-44F5-B718-E9C0D8312315Q33856490-B37415D2-81F4-4720-937C-5105EF85E4EDQ33893010-33E5A5AE-BC3E-4054-BE02-72FE727A893AQ34103978-9EC8AFD4-B017-4B62-8A65-CB3BC9A1EC78Q34361640-7D9666FB-D5BC-46BC-BE1D-5DFE9834CF58Q34442933-377CA30C-B1DB-4829-8E14-87328C21AF1BQ34528553-DD850C90-D71F-4737-9B52-FC55C71291ACQ34639023-8E5E2521-A7C9-494B-A45D-F242D96010A4Q34998994-15AD425A-FBCF-420A-9ACC-9DA5B5B3C2C7Q35140600-219B7567-1155-42D0-ACBE-8D4895FE7A46Q35168182-F7FFCF89-A3A9-43DF-941C-D846663D3200Q36039893-07E9BB80-90DB-4C2A-A56C-5629254B9B75Q36176058-44DA5010-162D-477B-A17F-496679F8F208Q36415602-06746AE4-F26F-4CC5-B4FE-6EAB798CF16AQ36416465-753BC33A-FEB1-4E89-993E-2C855DE7D9A1Q36569679-F353061C-1020-4297-BF48-E0566589BD16Q36604195-E8C5157A-AA1A-48A7-A1D1-A85FA3422188Q36750166-DDB9F68E-76F8-41B3-B81A-1508763933C2Q36847489-B3060BC4-97A4-48E7-8B01-C88BF789CEE3Q37017056-BA9FA82B-DA29-486A-AF12-E9D10C6760BAQ37081960-43BB760A-B1D7-49E3-B890-9B9AF4ECE07CQ37101060-B4261A90-4B2C-4505-BD65-7F087CAD4457Q37329264-9920C9E8-FDE9-4A2D-B359-EBCAE44FB463Q37390307-52EE1BCB-500B-4185-8A9C-05E1BF8FEAA0Q37483339-E9A2AA40-8EBD-4BCE-96E8-2D26ADB7D6C2Q38067435-5325AD8A-CE8C-4124-8B2F-C54DC4021A8AQ38067436-B06B2491-6733-4AC6-BCCF-5927C310FB47Q38687061-4793BD6C-A7FD-4A00-B896-0438A0331C81Q38787667-FD0A5CBB-AB0A-4EA0-B9C4-3C7F53797316Q39453522-36DD745D-E642-4C3F-85F9-63F93487B859Q39872610-55FFFE3F-9200-4953-9794-7441552A2B57Q43158887-A11AE77C-49DB-4057-A032-3105CDBDF10FQ44013238-8C5FDCEB-7412-4DB6-B02C-88F16E8D3931
P2860
The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The development of high-grade ...... nd molecular genetic analysis.
@ast
The development of high-grade ...... nd molecular genetic analysis.
@en
The development of high-grade serous carcinoma from atypical proliferative
@nl
type
label
The development of high-grade ...... nd molecular genetic analysis.
@ast
The development of high-grade ...... nd molecular genetic analysis.
@en
The development of high-grade serous carcinoma from atypical proliferative
@nl
prefLabel
The development of high-grade ...... nd molecular genetic analysis.
@ast
The development of high-grade ...... nd molecular genetic analysis.
@en
The development of high-grade serous carcinoma from atypical proliferative
@nl
P2093
P1476
The development of high-grade ...... nd molecular genetic analysis.
@en
P2093
Ie-Ming Shih
Reiko Dehari
Robert J Kurman
Sanjay Logani
P304
P356
10.1097/PAS.0B013E31802CBBE9
P407
P577
2007-07-01T00:00:00Z